J. Med. Toxicol. (2017) 13:293–302 DOI 10.1007/s13181-017-0630-8 ORIGINAL ARTICLE Non-health Care Facility Medication Errors Associated with Hormones and Hormone Antagonists in the United States 1,2 3,4 1,3,4 Pranav Magal & Henry A. Spiller & Marcel J. Casavant & 1 1,3 1,3,5 Thitphalak Chounthirath & Nichole L. Hodges & Gary A. Smith Received: 25 May 2017 /Revised: 29 July 2017 /Accepted: 30 August 2017 /Published online: 13 September 2017 American College of Medical Toxicology 2017 Abstract (21.9%), and insulin (20.0%). All nine deaths and Introduction Hormones and hormone antagonists are fre- 93.2% of major effects were attributed to hypoglycemic quently associated with medication errors and may re- agents. Sulfonylureas alone accounted 43.9% of major sult in important adverse outcomes. The purpose of this effects. The number and rate of therapeutic errors in- study is to investigate non-health care facility (non- creased significantly for all medication categories ex- HCF) medication errors associated with hormones and cept estrogen and thiazolidinediones. Most errors were hormone antagonists in the United States (US). managed at the site of exposure (82.9%) and did not Methods A retrospective analysis of National Poison Data result in serious medical outcomes (95.6%). System data was conducted to identify characteristics and
Journal of Medical Toxicology – Springer Journals
Published: Sep 13, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera